These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Rapid microdilution-colorimetric assay for yeast susceptibility to fluorocytosine. Fisher BD; Armstrong D Antimicrob Agents Chemother; 1977 Nov; 12(5):614-7. PubMed ID: 335966 [TBL] [Abstract][Full Text] [Related]
24. [Concentration-contact time relationship in the effect of antimycotic drug combinations (clotrimazole, nystatin, 5-fluorocytosine) and the effect of increasing and decreasing antimycotic drug concentrations on Candida albicans]. Rumler W; Heins S Mykosen; 1985 May; 28(5):251-7. PubMed ID: 3892290 [No Abstract] [Full Text] [Related]
25. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans]. Costa AL; Valenti A; Costa G; Calogero F G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772 [TBL] [Abstract][Full Text] [Related]
30. The effect of flucytosine on the germination of Candida albicans. Wain WH; Polak A Postgrad Med J; 1979 Sep; 55(647):671-3. PubMed ID: 392482 [TBL] [Abstract][Full Text] [Related]
31. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system. Ellis NS; Bartlett MS; Smith JW Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827 [TBL] [Abstract][Full Text] [Related]
32. Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates. Defever KS; Whelan WL; Rogers AL; Beneke ES; Veselenak JM; Soll DR Antimicrob Agents Chemother; 1982 Nov; 22(5):810-5. PubMed ID: 6758690 [TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine. Strippoli V; Torosantucci A; Simonetti N Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120 [TBL] [Abstract][Full Text] [Related]
34. [Sensitivity of yeasts against 5 fluorocytosine. Comparison of five methods (author's transl)]. Brinkmann F Z Hautkr; 1981 Oct; 56(19):1255-63. PubMed ID: 7032101 [TBL] [Abstract][Full Text] [Related]
35. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans. Chen HH; Liushih RN; Hsieh WC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097 [TBL] [Abstract][Full Text] [Related]
36. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans. Beggs WH; Sarosi GA Chemotherapy; 1982; 28(5):341-4. PubMed ID: 6754278 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms of action of 5-fluorocytosine. Waldorf AR; Polak A Antimicrob Agents Chemother; 1983 Jan; 23(1):79-85. PubMed ID: 6338821 [TBL] [Abstract][Full Text] [Related]
38. Control of yeast contamination with 5-fluorocytosine in the in vitro cultivation of Leishmania spp. Kimber CD; Evans DA; Robinson BL; Peters W Ann Trop Med Parasitol; 1981 Aug; 75(4):453-4. PubMed ID: 7030240 [No Abstract] [Full Text] [Related]
39. High performance liquid chromatographic determination of 5-fluorocytosine in human serum. Warnock DW; Turner A J Antimicrob Chemother; 1981 Apr; 7(4):363-9. PubMed ID: 7019185 [No Abstract] [Full Text] [Related]
40. Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans. Whelan WL; Kerridge D Antimicrob Agents Chemother; 1984 Oct; 26(4):570-4. PubMed ID: 6393861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]